| Primary |
| Antidepressant Therapy |
50.0% |
| Unevaluable Event |
50.0% |
|
| Contusion |
50.0% |
| Trigeminal Neuralgia |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
26.9% |
| Depression |
15.4% |
| Attention Deficit/hyperactivity Disorder |
11.5% |
| Pain |
7.7% |
| Routine Health Maintenance |
7.7% |
| Blood Triglycerides Increased |
3.8% |
| Erectile Dysfunction |
3.8% |
| Insomnia |
3.8% |
| Laxative Supportive Care |
3.8% |
| Musculoskeletal Pain |
3.8% |
| Neck Pain |
3.8% |
| Neuralgia |
3.8% |
| Schizoaffective Disorder Bipolar Type |
3.8% |
|
| Weight Increased |
33.3% |
| Nausea |
16.7% |
| Serotonin Syndrome |
16.7% |
| Urticaria |
16.7% |
| Vision Blurred |
16.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.3% |
| Depression |
11.2% |
| Asthma |
8.6% |
| Drug Use For Unknown Indication |
7.7% |
| Bipolar Disorder |
7.6% |
| Pain |
6.8% |
| Hypertension |
6.1% |
| Hepatitis C |
3.4% |
| Anxiety |
2.8% |
| Colitis Ulcerative |
2.0% |
| Hypothyroidism |
2.0% |
| Vitamin Supplementation |
2.0% |
| Postmenopause |
1.8% |
| Insomnia |
1.7% |
| Crohn's Disease |
1.6% |
| Major Depression |
1.6% |
| Restless Legs Syndrome |
1.6% |
| Blood Cholesterol Increased |
1.5% |
| Atrial Fibrillation |
1.4% |
| Blood Potassium |
1.4% |
|
| Weight Decreased |
11.0% |
| Weight Increased |
9.0% |
| Throat Tightness |
7.0% |
| Tremor |
7.0% |
| Vomiting |
7.0% |
| Wrong Technique In Drug Usage Process |
6.0% |
| Dehydration |
5.0% |
| Vision Blurred |
5.0% |
| Death |
4.0% |
| Dyspnoea |
4.0% |
| Nausea |
4.0% |
| Neuropathy Peripheral |
4.0% |
| Pain |
4.0% |
| Rash |
4.0% |
| Suicidal Ideation |
4.0% |
| Creatinine Renal Clearance |
3.0% |
| Dizziness |
3.0% |
| Drug Ineffective |
3.0% |
| Injection Site Urticaria |
3.0% |
| Nervousness |
3.0% |
|
